Back to dashboard
Episode 208
DIP Episode 208 - Transfusion Reactions
HematologyMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Transfusion reactions; Acute Hemolytic Transfusion Reaction (AHTR); Delayed Hemolytic Transfusion Reaction; Allergic reaction...
Key Takeaway
Transfusion reactions are diverse, ranging from Type I (Allergic) and Type II (Hemolytic) hypersensitivity to complex immune-mediated syndromes like TRALI and TAGVHD, requiring careful differentiation based on timing, mechanism, and hemodynamic status.
Runtime: 22.8 min
Published: 2020-02-06
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW, SPECIAL TOPICS/RISK FACTORS
Episode Notes
Source / episode info
- Episode: 208
- Title: Divine Intervention Episode 208 – Transfusion Reactions.
- Published: 2020-02-06
- Source: Episode page
One-liner
Episode 208 details six major transfusion reactions: AHTR (Type II, ABO error), Delayed Hemolysis (non-ABO antigens), Allergic (Type I, IgE crosslinking), FNHTR (cytokine release/Type III), TRALI (Anti-HLA complex deposition in lungs), TACO (fluid overload/cardiogenic edema), and TAGVHD (T-cell mediated attack).
High-yield summary
- Acute Hemolytic Transfusion Reaction (AHTR): Most common cause is ABO incompatibility (clerical error). Presents during transfusion with hematuria, flank pain. Mechanism: Type II hypersensitivity (preformed antibodies). Diagnosis: Direct Coombs Test positive.
- Allergic Reaction: Type I hypersensitivity. Triggered by transfused blood containing antigens to which the recipient has IgE antibodies. Presentation is predominantly airway/bronchospasm. Treatment requires immediate epinephrine.
- Febrile Non-Hemolytic Transfusion Reaction (FNHTR): Can be due to cytokine release from stored platelets/WB Cs (easy mechanism) or Type III hypersensitivity (recipient Ab attacking donor WB Cs, hard mechanism). Management: Antipyretics.
- TRALI: Non-cardiogenic pulmonary edema. Mechanism: Donor anti-HLA antibodies react with recipient leukocytes -> immune complex deposition in the lungs. Labs: PCWP < 18 mm Hg. Treatment: Supportive care; avoid diuretics.
- TACO: Cardiogenic pulmonary edema due to fluid overload from large volume transfusion. Mechanism: Heart failure exacerbation. Labs: PCWP > 18 mm Hg, elevated CVP/BNP. Management: Diuretics (e.g., furosemide).
- TAGVHD: T-cell mediated attack by donor T cells against recipient tissues. Risk factor: Immunocompromised recipient (e.g., post-BMT). Prevention: Gamma globulin administration or blood irradiation.
Learning objectives
- Differentiate between Type I, II, and III hypersensitivity reactions in the context of blood transfusion.
- Recognize the classic clinical presentation and underlying pathophysiology of AHTR vs. Delayed Hemolysis.
- Distinguish the pulmonary edema patterns (cardiogenic TACO vs. non-cardiogenic TRALI) using hemodynamic parameters (PCWP).
- Understand the mechanism and prevention strategies for T-cell mediated graft versus host disease (TAGVHD).
- Initiate appropriate supportive care, including fluid management and anti-inflammatory agents, based on the specific transfusion reaction.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Acute Hemolytic Transfusion Reaction (AHTR) | Flank pain, hematuria, fever; Direct Coombs positive | ABO incompatibility; Type II Hypersensitivity | Remember the timing: during transfusion. |
| TRALI | Non-cardiogenic pulmonary edema; PCWP < 18 mm Hg | Anti-HLA/Anti-WBC antibodies in donor blood; Type III Hypersensitivity | The low PCWP is critical for differentiating it from TACO. |
| TACO | Cardiogenic pulmonary edema; PCWP > 18 mm Hg; Elevated BNP | Fluid overload; Heart failure exacerbation | Treat with diuretics and fluid restriction, unlike TRALI. |
| Allergic Reaction | Bronchospasm, wheezing; IgE cross-linking | Transfused blood antigens; Type I Hypersensitivity | Immediate treatment requires epinephrine/antihistamines. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| AHTR | Hemolysis due to preformed antibodies (Type II) | ABO incompatibility, clerical error | High yield; always think of the timing and direct Coombs test. |
| TRALI vs TACO | TRALI: Low PCWP (<18); Non-cardiogenic edema. TACO: High PCWP (>18); Cardiogenic edema. | Transfusion complications; Hemodynamics | The most common trap question in this topic; focus on the pressure gradient. |
| Allergic Reaction | IgE crosslinking -> Mast cell degranulation (Type I) | Transfused blood antigens, mast cells | Requires immediate epinephrine administration for severe symptoms. |
| TAGVHD | T-cell mediated attack by donor cells on recipient tissues. | Immunocompromised patients (e.g., post-BMT); Donor T cells | Prevention involves gamma globulin or irradiation of the product. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient develops fever, chills, and flank pain shortly after receiving an incompatible blood transfusion (Type O recipient receives Type A). | Acute Hemolytic Transfusion Reaction (AHTR) | The timing (during the transfusion) and symptoms (flank pain/hematuria) are classic for acute intravascular hemolysis due to ABO incompatibility. |
| A patient with a history of multiple transfusions develops refractory hypoxemia, pulmonary infiltrates, and normal chest X-ray findings, but has a PCWP of 12 mm Hg. | Transfusion Related Acute Lung Injury (TRALI) | Non-cardiogenic edema (normal CXR/low PCWP) combined with transfusion risk points to TRALI. The low PCWP rules out TACO. |
| A patient receiving massive blood product transfusions, who has pre-existing heart failure and elevated BNP, develops bilateral crackles and pulmonary congestion. | Transfusion Associated Circulatory Overload (TACO) | This is a fluid overload state leading to cardiogenic edema. The high BNP and the clinical picture point to volume excess, not immune complex deposition. |
| A patient who recently underwent bone marrow transplantation develops fever, rash, and pancytopenia following transfusions; prophylaxis with gamma globulin was initiated. | Transfusion Associated Graft Versus Host Disease (TAGVHD) | This is a T-cell mediated rejection syndrome that occurs in immunocompromised hosts post-transplant. Gamma globulin prevents the donor T cells from attacking the recipient. |
| A patient develops wheezing and bronchospasm hours after receiving blood products, and their IgE levels are elevated. | Allergic Transfusion Reaction (Type I) | The hallmark of Type I hypersensitivity is mast cell degranulation mediated by IgE cross-linking, leading to acute airway symptoms. |
| A patient with a history of multiple transfusions develops fever days after the transfusion; the direct Coombs test is positive, but ABO incompatibility was ruled out. | Delayed Hemolytic Transfusion Reaction | The key differentiator is the timing (days later) and the non-ABO cause (e.g., Kidd or Kell antigens). |
Differential diagnosis / distinguishing features
TRALI vs TACO
| Key Features | Distinguishing Findings | Next Step |
| TRALI: Pulmonary edema is non-cardiogenic; low PCWP (<18 mm Hg). | TACO: Pulmonary edema is cardiogenic; high PCWP (>18 mm Hg). | If suspicion of TRALI, administer supportive care and avoid diuretics. |
| Pathophysiology: Immune complex deposition in the lungs (Type III). | Pathophysiology: Fluid overload/Heart failure exacerbation. | Monitor CVP and BNP levels to confirm fluid status. |
Management pearls
- AHTR: Aggressive IV fluid resuscitation is paramount to prevent acute tubular necrosis (ATN) from intravascular hemolysis.
- Allergic Reaction: Always treat severe reactions as anaphylaxis, regardless of initial stability; administer epinephrine promptly.
- TRALI: The primary treatment is supportive care and oxygenation; diuretics are contraindicated because they can worsen hypoxemia by reducing preload too much.
- TAGVHD: Prevention involves using gamma globulin or irradiating the blood product to neutralize donor T cells.
Don't miss
🚨
Clerical Error: ABO incompatibility remains the most common cause of severe AHTR and is a critical board-exam concept.
🚨
Hypersensitivity Types: Remember that Type I (Allergic) involves IgE/mast cells, Type II (AHTR) involves preformed antibodies attacking RB Cs, and Type III (TRALI/FNHTR) involves immune complex deposition.
🚨
Hemodynamic Distinction: The PCWP threshold of 18 mm Hg is the single most important lab value to differentiate TRALI from TACO.
Integration & clinical reasoning
- Immunology Integration: Transfusion reactions are excellent examples of how preformed antibodies (Type II), IgE crosslinking (Type I), and circulating immune complexes (Type III) manifest in clinical practice, reinforcing fundamental immunology principles.
- Nephrology/Pulmonary Connection: The mechanism of TRALI—immune complex deposition leading to capillary leak syndrome—is analogous to the pathophysiology seen in certain nephrotic or vasculitic syndromes where immune complexes deposit in organs.
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- For any patient presenting with acute respiratory failure (ARDS), standard emergency management (mechanical ventilation, oxygenation) takes priority over OMT.
- When managing suspected TACO/fluid overload, aggressive diuresis is appropriate and necessary to reduce pulmonary congestion; this contrasts sharply with the supportive care required for TRALI.
Concept connections / cross-references
- For a deeper dive into general transfusion medicine and blood typing, review [Episode 102].
- Understanding Type I/II/III hypersensitivity is foundational; see detailed reviews on immunology in [Episode 57].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| AHTR | ABO incompatibility (Type O -> A/B) | Preformed IgM antibodies attacking transfused RB Cs. | Requires immediate cessation of transfusion and aggressive fluid resuscitation. |
| TRALI | Anti-HLA or anti-WBC antibodies in donor blood. | Immune complex deposition in pulmonary capillaries; Type III hypersensitivity. | Leads to non-cardiogenic pulmonary edema, mimicking ARDS. |
| TACO | Large volume transfusion + Heart failure risk factors. | Fluid overload leading to elevated filling pressures (PCWP > 18). | Requires careful diuresis and fluid restriction to manage congestion. |
| Allergic Reaction | IgE cross-linking on mast cells/basophils. | Transfused antigens reacting with recipient IgE. | The primary life threat is bronchospasm, requiring epinephrine. |
Key terms glossary
| Term | Definition | Context | Example |
| Type I Hypersensitivity | Immediate reaction mediated by IgE binding to mast cells/basophils. | Allergic reactions (e.g., transfusion, insect sting). | Bronchospasm and flushing due to histamine release. |
| Direct Coombs Test | Detects antibodies bound directly to the surface of red blood cells. | Diagnosis of hemolytic anemia or AHTR. | Positive result strongly suggests an immune-mediated hemolytic process. |
| PCWP (Pulmonary Capillary Wedge Pressure) | Measures left atrial filling pressure; surrogate for pulmonary venous pressure. | Differentiating cardiogenic vs. non-cardiogenic edema. | Low PCWP (<18 mm Hg) favors TRALI; High PCWP (>18 mm Hg) favors TACO. |
| Gamma Globulin | Immunoglobulin product used to neutralize T cells or prevent antibody formation. | Prevention of TAGVHD in immunocompromised patients. | Administering it before transfusion helps mitigate the risk of donor T-cell attack. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Hemolytic Reactions | Focus on timing (acute vs delayed) and mechanism (Type II). | High | Review blood bank protocols; practice differentiating AHTR from other causes of hemolysis. |
| Pulmonary Edema Syndromes | Create a flow chart comparing TRALI, TACO, and ARDS based on PCWP and etiology. | Critical | Memorize the specific lab thresholds (PCWP < 18 vs > 18) for differentiation. |
| Immune Mechanisms | Review Type I, II, and III hypersensitivity reactions using clinical examples. | Medium-High | Use mnemonic devices to recall key triggers (e.g., IgE -> Allergic; Immune Complex -> TRALI). |
Question pattern recognition
- Mechanism Identification: Given a clinical scenario (e.g., fever post-transfusion), identify the underlying immunological mechanism (Type I, II, or III).
- Differential Diagnosis: Distinguishing between two similar but distinct conditions (e.g., TACO vs. TRALI) based on specific lab values and physical exam findings.
- Prevention/Management: Knowing the prophylactic measure (e.g., gamma globulin for TAGVHD) or immediate life-saving treatment (e.g., epinephrine for anaphylaxis).
Test yourself
Common mistakes to avoid
🚫
Confusing TRALI and TACO: The most common mistake is confusing the hemodynamic profiles. Always remember: Low PCWP = TRALI (non-cardiogenic); High PCWP = TACO (cardiogenic).
🚫
Assuming all transfusion reactions are Type II: While AHTR is Type II, allergic reactions are Type I, and TRALI/FNHTR are Type III. The mechanism dictates the management.
🚫
Ignoring Timing in Hemolysis: Failing to distinguish between acute hemolysis during transfusion (AHTR) versus delayed hemolysis days later (non-ABO antigens).
Common traps
⚠️
The "Low PCWP" Trap: A low PCWP (<18 mm Hg) is often misinterpreted as normal, but when combined with a recent blood transfusion and pulmonary edema, it strongly suggests TRALI.
⚠️
The "Diuretic Use" Trap: In the setting of suspected TRALI, giving diuretics (like furosemide) can be fatal because they reduce preload and worsen hypoxemia by reducing cardiac output.
⚠️
The "Primary Cause" Trap: Assuming that all severe transfusion reactions are due to ABO incompatibility; always consider non-ABO antigens for delayed hemolysis or immune complex formation for TRALI.